Regulation of microglial proliferation during chronic neurodegeneration

Diego Gómez-Nicola1, Nina L Fransen, Stefano Suzzi

  • 1Centre for Biological Sciences, University of Southampton, SO16 6YD, Southampton, United Kingdom. d.gomez-nicola@soton.ac.uk

Insights

Microglial proliferation drives neuroinflammation in chronic diseases like Alzheimer's. Targeting CSF1R signaling reduces this proliferation, slowing neuronal damage and disease progression.

Area of Science:

  • Neuroscience
  • Immunology
  • Cell Biology

Background:

  • Chronic neurodegenerative diseases involve central nervous system (CNS) inflammation.
  • Microglial and astroglial cells are key players in this inflammatory response, exhibiting increased proliferation and activation.

Purpose of the Study:

  • To investigate the temporal dynamics and regulatory mechanisms of microglial proliferation in a mouse model of prion disease.
  • To identify molecular pathways governing microglial expansion during neurodegeneration.

Main Methods:

  • Utilized a mouse model of prion disease to study microglial proliferation.
  • Analyzed the role of CSF1R signaling and transcription factors PU.1 and C/EBPα.
  • Assessed the impact of targeting CSF1R on disease progression and neuronal damage.

Main Results:

  • Microglial cell proliferation was identified as the primary driver of microglial population expansion during disease development.
  • The CSF1R pathway, regulated by PU.1 and C/EBPα, was identified as a key molecular regulator of microglial proliferation.
  • Inhibition of CSF1R activity effectively reduced microglial proliferation, mitigated neuronal damage, and slowed disease progression.

Conclusions:

  • Microglial proliferation is a significant factor in the progression of chronic neurodegenerative diseases.
  • The findings highlight the critical role of the CNS innate immune response in disease evolution.
  • Targeting CSF1R offers a potential therapeutic strategy for neurodegenerative conditions.